ABS Biotechnologies GmbH
About
ABS Biotechnologies GmbH is an Austrian biotechnology company developing advanced human iPSC-derived cardiovascular cell models and screening platforms for drug discovery, disease modelling, and toxicology testing. We provide ethnically diverse human iPSC lines and advanced vascular and cardiac models that enable more predictive, human-relevant preclinical research. Our innovative platforms help pharmaceutical and biotech companies improve drug safety assessment, accelerate drug discovery, and develop more effective therapies for diverse patient populations
Representatives
On-site
On-site
CEO
ABS Biotechnologies GmbH